Mechanistic insights into mesenchymal-amoeboid transition as an intelligent cellular adaptation in cancer metastasis and resistance
- PMID: 38960056
- DOI: 10.1016/j.bbadis.2024.167332
Mechanistic insights into mesenchymal-amoeboid transition as an intelligent cellular adaptation in cancer metastasis and resistance
Abstract
Malignant cell plasticity is an important hallmark of tumor biology and crucial for metastasis and resistance. Cell plasticity lets cancer cells adapt to and escape the therapeutic strategies, which is the leading cause of cancer patient mortality. Epithelial cells acquire mobility via epithelial-mesenchymal transition (EMT), whereas mesenchymal cells enhance their migratory ability and clonogenic potential by acquiring amoeboid characteristics through mesenchymal-amoeboid transition (MAT). Tumor formation, progression, and metastasis depend on the tumor microenvironment (TME), a complex ecosystem within and around a tumor. Through increased migration and metastasis of cancer cells, the TME also contributes to malignancy. This review underscores the distinction between invasion pattern morphological manifestations and the diverse structures found within the TME. Furthermore, the mechanisms by which amoeboid-associated characteristics promote resistance and metastasis and how these mechanisms may represent therapeutic opportunities are discussed.
Keywords: Amoeboid-mesenchymal transition; Extracellular matrix; Focal adhesion kinase; GTPase-activating protein; Guanine nucleotide exchange factor; Small GTPase.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.Curr Biol. 2017 Feb 6;27(3):392-400. doi: 10.1016/j.cub.2016.11.057. Epub 2017 Jan 12. Curr Biol. 2017. PMID: 28089517
-
Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers.Biomed Pharmacother. 2024 Dec;181:117714. doi: 10.1016/j.biopha.2024.117714. Epub 2024 Nov 29. Biomed Pharmacother. 2024. PMID: 39615165 Review.
-
Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells.Int Rev Cell Mol Biol. 2020;356:197-256. doi: 10.1016/bs.ircmb.2020.06.002. Epub 2020 Jul 16. Int Rev Cell Mol Biol. 2020. PMID: 33066874 Free PMC article. Review.
-
Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.Dev Dyn. 2018 Mar;247(3):405-431. doi: 10.1002/dvdy.24548. Epub 2017 Sep 18. Dev Dyn. 2018. PMID: 28691356 Review.
-
The amoeboid state as part of the epithelial-to-mesenchymal transition programme.Trends Cell Biol. 2022 Mar;32(3):228-242. doi: 10.1016/j.tcb.2021.10.004. Epub 2021 Nov 23. Trends Cell Biol. 2022. PMID: 34836782 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical